A Study of LY3471851 in Participants With Eczema
Condition: Dermatitis, Atopic Interventions: Drug: LY3471851; Drug: Placebo Sponsors: Eli Lilly and Company; Nektar Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials